New Sales Agent and Distributor Gains Quick Traction in the Region
FREDERICK, Md., Sept. 18 /PRNewswire-FirstCall/ -- BioElectronics Corporation (BIEL) announced today that the new sales agent it announced last week, Abdulkader Al-Mehyar Moh'd Basheer Halawy has taken for approximately $400,000 in new sales in the Middle Eastern region.
"We are pleased that the new agent has hit the ground running and is finding wide marketing acceptance for our products. We look forward to significant repeat sales as the product is distributed throughout the territory," said Farid Tamimi V.P. of International Sales of BioElectronics Corporation. "There is strong demand for our inexpensive, drug-free medical products in the Middle East and other international markets."
BioElectronics Corporation (Pink Sheets: BIEL) is the maker of inexpensive, drug-free, anti-inflammatory medical devices and patches. The Company's inexpensive wafer thin patches and devices contain an embedded microchip and battery that deliver pulsed electromagnetic energy, a clinically proven and widely accepted anti-inflammatory and pain relief therapy that heretofore has only been possible to obtain from large, facility-based equipment. BioElectronics markets and sells its current products under the brand names ActiPatch(TM) and RecoveryRx(TM). The dermal patch delivery system creates a multitude of new product opportunities for chronic and acute inflammatory conditions.
For more information visit http://www.bioelectronicscorp.com or call 866-757-2284.
Information on ActiPatch and BioElectronics Corporation is available at
the following websites:
-- Podiatry: http://www.pemfpodiatry.com
-- German orthopedic foot & ankle: http://www.diesfussexperten.de
-- Italy and Switzerland: http://www.actipatch.it
-- Canada: http://www.actipatchpaintherapy.ca
-- Netherlands: http://www.actipatch.de
-- Singapore & Malaysia: http://www.astonixlife.com/
-- Denmark: http://www.c-m-a.dk
-- BioElectronics Corp: http://www.bioelectronicscorp.com
Safe Harbor Statement
This news release contains forward-looking statements related to future
growth and earnings opportunities. Such statements are based upon certain
assumptions and assessments made by management in light of current
conditions, expected future developments and other factors it believes to
be appropriate. Actual results may differ as a result of factors over which
the company has no control.
Andrew J. Whelan
4539 Metropolitan Court
Frederick, MD 21704
866-757-2284 ext 107
301-874-4890 ext 107
|SOURCE BioElectronics Corporation|
Copyright©2008 PR Newswire.
All rights reserved